Quantitative assessment of DNA fragmentation and beta-amyloid deposition in insular cortex and midfrontal gyrus from patients with Alzheimer's disease

Life Sciences

Volumn 73, Issue 14, 2003, Pages 1795-1803

  Colurso, Gloria J ^a   Nilson, James E ^a   Vervoort, Lucia G ^a  

^a EASTERN CONNECTICUT STATE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Apoptosis; Beta amyloid; Insular cortex; Midfrontal gyrus

Indexed keywords

AMYLOID BETA PROTEIN; DNA FRAGMENT;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN REGION; BRAIN TISSUE; CELL DAMAGE; CELL LOSS; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA STRAND BREAKAGE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; INSULA; NEUROPATHOLOGY; NICK END LABELING; PYRAMIDAL NERVE CELL; SENILE PLAQUE; TISSUE SECTION;

EID: 0041846404     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00512-5     Document Type: Article

References (37)

1. Adamec E., Vonsattel J.P., Nixon R.A. DNA strand breaks in Alzheimer's disease. Brain Research. 849:1999;67-77.
2. Anderson A.J., Su J.H., Cotman C.W. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. Journal of Neuroscience. 16:1996;1710-1719.
3. Arriagada P.V., Growdon J.H., Hedley-Whyte E.T., Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:1992;631-639.
4. Behl C. Apoptosis and Alzheimer's disease. Journal of Neural Transmission. 107:2000;1325-1344.
5. Berk K.N. Data Analysis with Student SYSTAT. Macintosh Edition:1994;Course Technology Inc, Cambridge.
6. Butterfield D.A., Griffin S., Munch G., Pasinetti G.M. Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. Journal of Alzheimer's Disease. 4:2002;193-201.
7. Casal C., Serratosa J., Tusell J.M. Relationship between beta-AP peptide aggregation and microglial activation. Brain Research. 928:2002;76-84.
8. Colurso G.J., Kan R.K., Anthony A. Microdensitometric measures of cytoplasmic RNA and total protein in pyramidal neurons of the insular cortex and midfrontal gyrus in patients with Alzheimer's disease. Cell Biochemistry and Function. 13:1995;287-292.
9. Cotman C.W., Pike C.J. Apoptosis in Alzheimer's disease. Inductive agents and antioxidant protective factors. Fisher A., Hanin I., Yoshida M. Progress in Alzheimer's and Parkinson's Diseases. 1998;45-51 Plenum Press, New York.
10. Czech C., Tremp G., Pradier L. Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms. Progress in Neurobiology. 60:2000;363-384.
11. Demeester N., Baier G., Enzinger C., Goethals M., Vandekerckhove J., Rosseneu M., Labeur C. Apoptosis induced in neuronal cells by C-terminal amyloid β-fragments is correlated with their aggregation properties in phospholipid membranes. Molecular Membrane Biology. 17:2000;219-228.
12. Engidawork E., Gulesserian T., Yoo B.C., Cairns N., Lubec G. Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease. Biochemical and Biophysical Research Communications. 281:2001;84-93.
13. Forloni G., Bugiani O., Tagliavini F., Salmona M. Apoptosis-mediated neurotoxicity induced by β-amyloid and PrP fragments. Molecular and Chemical Neuropathology. 28:1996;163-171.
14. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. Journal of Cell Biology. 119:1992;493-501.
15. Honig L.S., Rosenberg R.N. Apoptosis and neurologic disease. American Journal of Medicine. 108:2000;317-330.
16. Jellinger K.A., Stadelmann C. Mechanisms of cell death in neurodegenerative disorders. Journal of Neural Transmission. 59:2000;95-114.
17. Labat-Moleur F., Guillermet C., Lorimier P., Robert C., Lantuejoul S., Brambilla E., Negoescu A. TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement. Journal of Histochemistry and Cytochemistry. 46:1998;327-334.
18. Li W.P., Chan W.Y., Lai H.W.L., Yew D.T. Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients. Journal of Molecular Neuroscience. 8:1997;75-82.
19. Lin H., Bhatia R., Lal R. Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology. Federation of American Societies for Experimental Biology. 15:2001;2433-2444.
20. Loo D.T., Copani A.G., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proceedings of the National Academy of Sciences, USA. 90:1993;7951-7955.
21. Lucassen P.J., Chung W.J.C., Kamphorst W., Swaab D.F. DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology. Journal of Neuropathology and Experimental Neurology. 56:1997;887-900.
22. Mattson M.P., Partin J., Begley J.G. Amyloid β-peptide induces apoptosis-related events in synapses and dendrites. Brain Research. 807:1998;167-176.
23. Neve R.L., Robakis N.K. Alzheimer's disease: a re-examination of the amyloid hypothesis. Trends in Neuroscience. 21:1998;15-19.
24. Phinney A.L., Deller T., Stalder M., Calhoun M.E., Frotscher M., Sommer B., Staufenbiel M., Jucker M. Cerebral amyloid induces aberrant axon sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. Journal of Neuroscience. 19:1999;8552-8559.
25. Roth K. Caspases, apoptosis, and Alzheimer's disease: causation, correlation, and confusion. Journal of Neuropathology and Experimental Neurology. 60:2001;829-838.
26. Saunders A.M. Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses. Journal of Neuropathology and Experimental Neurology. 59:2000;751-758.
27. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid β-protein. Annals of the New York Academy of Sciences. 924:2000;17-25.
28. Shearman M.S. Amyloid-β hypothesis of Alzheimer's disease. Fisher A., Hanin I., Yoshida M. Progress in Alzheimer's and Parkinson's Diseases. 1998;187-190 Plenum Press, New York.
29. Sheng J.G., Zhou X.Q., Mrak R.E., Griffin W.S. Progressive neuronal injury associated with amyloid plaque formation in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 57:1998;714-717.
30. Smale G., Nichols N.R., Brady D.R., Finch C.E., Horton W.E. Evidence for apoptotic cell death in Alzheimer's disease. Experimental Neurology. 133:1995;225-230.
31. Stadelmann C., Bruck W., Bancher C., Jellinger K., Lassmann H. Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. Journal of Neuropathology and Experimental Neurology. 57:1998;456-464.
32. Stadelmann C., Lassmann H. Detection of apoptosis in tissue sections. Cell and Tissue Research. 301:2000;19-31.
33. Sugaya K., Reeves M., McKinney M. Topographic associations between DNA fragmentation and Alzheimer's disease neuropathology in the hippocampus. Neurochemistry International. 31:1997;275-281.
34. Terry R.D. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. Journal of Neuropathology and Experimental Neurology. 55:1996;1023-1025.
35. Troncoso J.C., Sukhov R.R., Kawas C.H., Koliatsos V.E. In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: correlations with senile plaques and disease progression. Journal of Neuropathology and Experimental Neurology. 55:1996;1134-1142.
36. Verbeek M.M., Ruiter D.J., deWaal R.M.W. The role of amyloid in the pathogenesis of Alzheimer's disease. Biological Chemistry. 378:1997;937-950.
37. Willingham M.C. Cytochemical methods for the detection of apoptosis. Journal of Histochemistry and Cytochemistry. 47:1999;1101-1110.